Depemokimab demonstrates efficacy in patients with type 2 asthma with comorbid CRSwNP: Phase III SWIFT-1/-2 analysis

20260 citationsJournal Articlegold Open Access

Authors

NCT04719832/NCT04718103.

Good health and well-being

Published in: Frontiers in Allergy

Volume 7, pp. 1766647-1766647

Field-Weighted Citation Impact: 0.00